Literature DB >> 3608151

Melatonin secretion in humans assessed by measuring its metabolite, 6-sulfatoxymelatonin.

C J Bojkowski, J Arendt, M C Shih, S P Markey.   

Abstract

Comparing a direct radioimmunoassay for 6-sulfatoxymelatonin (aMT6s) with an established gas chromatographic/mass spectrometric method for 6-hydroxymelatonin, we found a good correlation r = 0.94 (P less than 0.001, n = 100). aMT6s was stable, both in urine and plasma samples, without preservative, for at least two years at -20 degrees C and for five days at room temperature. Urinary excretion of aMT6s showed considerable inter-individual differences; however, the aMT6s excretion of any one individual was consistent over a four-day period, as assessed by continuous collection from 18 normal volunteers. Total 24-h urinary excretion of aMT6s was significantly correlated with the area under the curve of the respective profiles for plasma melatonin (r = 0.75, P = 0.0002) and plasma aMT6s (r = 0.70, P = 0.0005) for 22 healthy volunteers. At 24:00 h and 03:00 h, sampling plasma at 30-s intervals provided no evidence for episodic secretion (in short pulses) of either melatonin or aMT6s.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3608151

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  28 in total

1.  Circadian rhythm disruption in severe sepsis: the effect of ambient light on urinary 6-sulfatoxymelatonin secretion.

Authors:  Avelino C Verceles; Leann Silhan; Michael Terrin; Giora Netzer; Carl Shanholtz; Steven M Scharf
Journal:  Intensive Care Med       Date:  2012-05       Impact factor: 17.440

2.  General anesthesia for surgery influences melatonin and cortisol levels.

Authors:  Edward Ram; Tali H Vishne; Talia Weinstein; Benzion Beilin; Zeev Dreznik
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

3.  Melatonin deficiency and disrupted circadian rhythms in pediatric survivors of craniopharyngioma.

Authors:  J Lipton; J T Megerian; S V Kothare; Y-J Cho; T Shanahan; H Chart; R Ferber; L Adler-Golden; L E Cohen; C A Czeisler; S L Pomeroy
Journal:  Neurology       Date:  2009-07-28       Impact factor: 9.910

Review 4.  Positive and negative effects of mechanical ventilation on sleep in the ICU: a review with clinical recommendations.

Authors:  Nuttapol Rittayamai; Elizabeth Wilcox; Xavier Drouot; Sangeeta Mehta; Alberto Goffi; Laurent Brochard
Journal:  Intensive Care Med       Date:  2016-01-13       Impact factor: 17.440

5.  The Effects of Timed Light Exposure in Critically Ill Patients: A Randomized Controlled Pilot Clinical Trial.

Authors:  Brian K Gehlbach; Shruti B Patel; Eve Van Cauter; Anne S Pohlman; Jesse B Hall; Joseph Zabner
Journal:  Am J Respir Crit Care Med       Date:  2018-07-15       Impact factor: 21.405

6.  Temporal dynamics of circadian phase shifting response to consecutive night shifts in healthcare workers: role of light-dark exposure.

Authors:  Julia E Stone; Tracey L Sletten; Michelle Magee; Saranea Ganesan; Megan D Mulhall; Allison Collins; Mark Howard; Steven W Lockley; Shantha M W Rajaratnam
Journal:  J Physiol       Date:  2018-04-06       Impact factor: 5.182

7.  Shift Work, Chronotype, and Melatonin Rhythm in Nurses.

Authors:  Pedram Razavi; Elizabeth E Devore; Archna Bajaj; Steven W Lockley; Mariana G Figueiro; Vincent Ricchiuti; W James Gauderman; Susan E Hankinson; Walter C Willett; Eva S Schernhammer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-05-29       Impact factor: 4.254

8.  Comparison of the effects of acute fluvoxamine and desipramine administration on melatonin and cortisol production in humans.

Authors:  D J Skene; C J Bojkowski; J Arendt
Journal:  Br J Clin Pharmacol       Date:  1994-02       Impact factor: 4.335

9.  Diurnal variation of melatonin and cortisol is maintained in non-septic intensive care patients.

Authors:  Asko Riutta; Pauli Ylitalo; Seppo Kaukinen
Journal:  Intensive Care Med       Date:  2009-07-04       Impact factor: 17.440

10.  Urinary 6-sulfatoxymelatonin level in age-related macular degeneration patients.

Authors:  Richard Rosen; Dan-Ning Hu; Violete Perez; Katy Tai; Guo-Pei Yu; Min Chen; Paul Tone; Steven A McCormick; Joseph Walsh
Journal:  Mol Vis       Date:  2009-08-21       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.